Theraclion SA (EPA:ALTHE)

France flag France · Delayed Price · Currency is EUR
0.610
+0.004 (0.66%)
At close: Dec 5, 2025
67.12%
Market Cap 28.66M
Revenue (ttm) 1.87M
Net Income (ttm) -5.25M
Shares Out 46.98M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,958
Average Volume 40,449
Open 0.606
Previous Close 0.606
Day's Range 0.600 - 0.620
52-Week Range 0.142 - 1.250
Beta -0.12
RSI 43.11
Earnings Date Dec 23, 2025

About Theraclion

Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2004
Employees 32
Stock Exchange Euronext Paris
Ticker Symbol ALTHE
Full Company Profile

Financial Performance

In 2024, Theraclion's revenue was 830,209, a decrease of -54.44% compared to the previous year's 1.82 million. Losses were -5.76 million, 56.7% more than in 2023.

Financial Statements

News

There is no news available yet.